Antony C. Mattessich, President and C.E.O at OCULAR THERAPEUTIX, INC (OCUL), bought 21,000 shares at $4.29 ($90K) on 2017-12-12, disclosed to the SEC on 2017-12-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| OCUL | BUY | 2023-09-05 | $25K | — | Filing → |
| OCUL | SELL | 2023-02-08 | $167K | — | Filing → |
| OCUL | BUY | 2021-08-24 | $49K | — | Filing → |